Powered by

LI-COR Biosciences Introduces DigiWest to Accelerate Targeted Therapeutics Development

Aug 06, 2019 - PR Newswire

PR Newswire

 Researchers can identify therapeutic targets and functional effects of targeted therapeutics more quickly and efficiently as part of a complete solution now offered by LI-COR Biosciences in partnership with NMI TT Pharmaservices. DigiWest High-Content Protein Profiling Services speed the process of developing relevant therapeutics. It is a versatile platform for pathway profiling, drug mode-of-action studies, functional characterization of compounds (small molecules, PROTACs,...